Kevin Cureton - 26 Nov 2021 Form 4 Insider Report for NANOPHASE TECHNOLOGIES Corp (SLSN)

Role: Chief Operating Officer
Signature: /s/ Jess Jankowski under UPA for Kevin Cureton
Issuer symbol: SLSN
Transactions as of: 26 Nov 2021
Net transactions value: -$134,436
Form type: 4
Filing time: 30 Nov 2021, 19:09:23 UTC
Previous filing: 24 Nov 2021
Next filing: 30 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NANX	Common Stock	Options Exercise	$6,556	+12,607	+49%	$0.5200	38,257	26 Nov 2021	Direct
transaction	NANX	Common Stock	Sale	$44,124	-12,607	-33%	$3.50	25,650	26 Nov 2021	Direct
transaction	NANX	Common Stock	Options Exercise	$9,960	+24,000	+94%	$0.4150	49,650	30 Nov 2021	Direct
transaction	NANX	Common Stock	Options Exercise	$13,000	+25,000	+50%	$0.5200	74,650	30 Nov 2021	Direct
transaction	NANX	Common Stock	Sale	$90,312	-23,829	-32%	$3.79	50,821	30 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NANX	Common Stock (right to purchase)	Options Exercise	$9,960	-24,000	-100%	$0.4150	0	30 Nov 2021	Common Stock	24,000	$0.4150	Direct	F1, F2
transaction	NANX	Common Stock	Options Exercise	$6,556	-12,607	-100%	$0.5200	0	26 Nov 2021	Common Stock	12,607	$0.5200	Direct	F2, F3
transaction	NANX	Common Stock (right to purchase)	Options Exercise	$13,000	-25,000	-50%	$0.5200	25,000	30 Nov 2021	Common Stock	50,000	$0.5200	Direct	F2, F4
holding	NANX	Common Stock (right to purchase)						50,000	26 Nov 2021	Common Stock	50,000	$0.4400	Direct	F2
holding	NANX	Common Stock (right to purchase)						43,500	26 Nov 2021	Common Stock	43,500	$0.4200	Direct	F2
holding	NANX	Common Stock (right to purchase)						50,000	26 Nov 2021	Common Stock	50,000	$0.6800	Direct	F2
holding	NANX	Common Stock (right to purchase)						80,000	26 Nov 2021	Common Stock	80,000	$0.8200	Direct	F2
holding	NANX	Common Stock (right to purchase)						16,500	26 Nov 2021	Common Stock	16,500	$0.5100	Direct	F2
holding	NANX	Common Stock (right to purchase)						90,000	26 Nov 2021	Common Stock	90,000	$0.4500	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Following recently reported exercises of 11,668 (11/22/21) and 12,332 (11/24/21) shares, this line item represents the 3rd exercise, of 24,000 shares of the total initial grant of 48,000 shares, leaving a balance of 0 shares remaining relating to this grant.
F2	Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
F3	Following the recently reported exercise of 12,393 shares (11/24/21), this line item represents the 2nd exercise, of 12,607 shares of a total initial grant of 75,000 shares, leaving a balance of 50,000 shares remaining relating to this grant, prior to the 11/30/21 exercise reported below.
F4	Following the recently reported exercise of 12,393 shares (11/24/21), and the 2nd exercise of 12,607 shares (11/26/21, reported above) this line item represents the 3rd exercise, of 25,000 shares of the total initial grant of 75,000 shares, leaving a balance of 25,000 shares remaining relating to this grant.